PHS
NTRA icon

PFM Health Sciences’s Natera NTRA Stock Holding History

PFM Health Sciences’s Portfolio NTRA Stock Details NTRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.99M Sell
22,077
-37,927
-63% -$8.09M 0.51% 63
2026
Q1 		$12M Buy
+60,004
New +$12.9M 1.09% 28
2025
Q4 		– Sell
-115,596
Closed -$18.6M – 97
2025
Q3 		$18.6M Buy
115,596
+14,346
+14% +$2.27M 1.43% 21
2025
Q2 		$17.1M Buy
+101,250
New +$15.8M 1.46% 22

Other funds holding NTRA

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PFM Health Sciences's NTRA Position: Q2 2026 in Review

PFM Health Sciences reduced its Natera (NTRA) stake by 63% in Q2 2026, selling an estimated $8.09M and leaving 22,077 shares worth $5.99M. The position accounts for 0.51% of the portfolio, ranked #63.

PFM Health Sciences first reported a position in NTRA in Q2 2025 and has held it in 4 quarters since. The position peaked at $18.6M in Q3 2025. 847 funds tracked by Wall St. Rank hold NTRA as of Q2 2026.

  • PFM Health Sciences held 22,077 shares of Natera worth $5.99M as of Q2 2026.
  • PFM Health Sciences sold 37,927 Natera shares in Q2 2026, an estimated $8.09M.
  • Natera made up 0.51% of PFM Health Sciences's portfolio in Q2 2026, its #63 holding.
  • PFM Health Sciences first reported a position in Natera in Q2 2025 and has held it in 4 quarters since.
  • PFM Health Sciences's Natera position peaked at $18.6M in Q3 2025.
  • 847 funds tracked by Wall St. Rank held Natera as of Q2 2026.

Based on PFM Health Sciences's 13F filing for Q2 2026, filed 14 Aug 2026.